GlassScriptPhysician profile
Christopher M Andriano
NPI 1922549351
$40,743.18
in general payments reported to CMS, 2019-2025
22 companies · $1,287 in 2025
The $1,287 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.68 · 2020: $144 · 2021: $264 · 2022: $27K · 2023: $4,548 · 2024: $7,538 · 2025: $1,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,319 · Food and Beverage: $4,916 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,318.90 |
| Food and Beverage | $4,915.97 |
| Education | $138.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,912.80 | 2021-2025 | Vanta Adaptivestim, Intellis Adaptivestim |
| Boston Scientific Corporation | $13,410.98 | 2022-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $8,266.71 | 2023-2025 | Proclaim, Eterna |
| Nevro Corp. | $455.84 | 2020-2024 | Senza |
| Spr Therapeutics, INC | $223.53 | 2021-2022 | |
| Curonix LLC | $211.26 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $188.97 | 2023-2025 | Belbuca, Xtampza |
| Biotronik Nro, INC. | $184.99 | 2025 | Prospera |
| Spinal Simplicity, LLC | $157.19 | 2024-2025 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $141.74 | 2023-2025 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $114.30 | 2022 | |
| Relievant Medsystems, INC. | $103.58 | 2022 | |
| Avanos Medical | $94.50 | 2022 | |
| Foundation Fusion Solutions, LLC | $60.37 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $44.55 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $41.82 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $28.70 | 2025 | Senza |
| Averitas Pharma INC. | $26.36 | 2024 | Qutenza |
| Bard Access Systems, INC. | $21.68 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $20.91 | 2022 | |
| Allergan, INC. | $16.92 | 2021 | |
| Valinor Pharma, LLC | $15.48 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Andriano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.